biOasis Technologies Ord Shs V.BTI.H

Alternate Symbol(s): BIOAF

Healthcare Biotechnology

Bioasis Technologies Inc. is a Canada-based biopharmaceutical company focused on research and development of technologies and products intended for the treatment of patients with nervous system, including central nervous system, diseases and disorders. The Company is engaged in the development of its xB 3 platform, which is a peptide-based technology, for the transport of therapeutic agents, in particular biological products, across the blood-brain barrier (BBB). It is focused on both orphan drug indications, including brain cancers, and rare genetic neurodegenerative diseases and neuroinflammatory conditions. The Company is also focused on its Epidermal Growth Factor (EGF) platform for treating rare and orphan neurodegenerative and neuroinflammatory disorders. EGF is a protein that stimulates cell growth and differentiation, notably for myelin producing cells. Its development programs include xB3-001: Brain Metastases, xB3-002: Glioblastoma and xB3-007: Neurodegenerative Disease.

TSXV:BTI.H - Post by User

biOasis Technologies Ord Shs

<< Previous

Bullboard Posts

Next >>

Post by Sniper007on Nov 23, 2020 2:42pm

868 Views

Post# 31954111

Hope for deals, not a buyout... yet!!!

Hope for deals, regardless, not a $3-5 buyout.

Deals first, a significant run in the market, then maybe consider a buyout.

But make no mistake about it, if a pharma offers us a buyout it's because they think the technology is sound. If the technology is sound, it aint worth $3-5 dollars!!!

Have you heard of our competitor Denali? It's ticker symbol is DNLI and is traded on the Nasdaq. Check it out! It recently reached $70 a share and our technology would seem to be superior.

DrDR told me she expects Bioasis to be worth "Billions". That not $3-5 a share!

Sniper

<< Previous

Bullboard Posts

Next >>

Dynamic Funds Launches new ETF series on the TSX